Vitality Watch

Dossier pubmed observational 29-oct-2026
Human cohort, case-control, or epidemiological association

Stage-Dependent Sarcopenia Status in Parkinson’s Disease: An ICF-Based ISarcoPRM Algorithm.

Key claim: Muscle mass, strength, and physical performance impairments in Parkinson’s disease are stage-dependent and become significantly elevated only in moderate-stage disease.

Abstract

OBJECTIVE: This study aimed to determine sarcopenia status in patients with Parkinson’s disease (PD), classified as early-stage (<2.5) and moderate-stage (≥2.5) by the Modified Hoehn and Yahr Scale, and in healthy controls using the ICF-based ISarcoPRM algorithm. DESIGN: A total of 63 participants were included in this cross-sectional study: 42 patients with PD and 21 healthy controls. Muscle mass was assessed using ultrasonographic anterior thigh thickness (ATT) and the Sonographic Thigh Adjustment Ratio (STAR), muscle strength by handgrip dynamometry, and physical performance by the five-times sit-to-stand test (5xSTS). Participants were classified as non-sarcopenic, dynapenic, or sarcopenic according to ISarcoPRM criteria. RESULTS: The prevalence of sarcopenia differed significantly across groups (P=0.016), with higher rates observed in patients with moderate-stage PD. Adjusted analyses showed significant overall group differences in ATT, handgrip strength, STAR, and 5xSTS performance, with muscle-related impairments generally more pronounced in the moderate-stage PD group. No significant differences were found between early-stage PD and healthy controls. CONCLUSION: Muscle-related impairments in PD appear to be stage-dependent and become more pronounced in moderate stages. Comprehensive assessment approaches integrating muscle morphology, strength, and physical performance may provide clinically relevant insights for individualized rehabilitation strategies.

Why this matters

Muscle mass, strength, and physical performance impairments in Parkinson’s disease are stage-dependent and become significantly elevated only in moderate-stage disease.

Source

Link

Briefing card

Stage-Dependent Sarcopenia Status in Parkinson's Disease: An ICF-Based ISarcoPRM Algorithm.
Stage: observational · pubmed · 29-oct-2026

Muscle mass, strength, and physical performance impairments in Parkinson's disease are stage-dependent and become significantly elevated only in moderate-stage disease.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1097/PHM.0000000000003188

build build 880 · 2bcef25 · 2026-11-18